China (Mainland)
Atosiban Acetate CAS NO.90779-69-4
- Min.Order: 1 Gram
- Payment Terms: L/C,T/T,MoneyGram
- Product Details
Keywords
- Atosiban Acetate/Vapreotide Acetate
- CAS 90779-69-4
- custom peptides/Somatostatin Acetate
Quick Details
- ProName: Atosiban Acetate
- CasNo: 90779-69-4
- Molecular Formula: C43H67N11O12S2
- Appearance: white powder
- Application: peptide,custom peptides,cosmetic pepti...
- DeliveryTime: 7DAYS
- PackAge: 1G/BAG,10G/BAG
- Port: SHANGHAI
- ProductionCapacity: 20 Kilogram/Month
- Purity: 99%
- Storage: -20℃
- Transportation: 2-8degree
- LimitNum: 1 Gram
- Moisture Content: 1%
- Impurity: 0.2%
Superiority
Atosiban Acetate
IN STOCK
QUICK OVERVIEW
Product Name Atosiban Acetate;
Cas No. 90779-69-4;
Sequence Mpa-D-Tyr(ET)-Ile-Thr-Asn-Cys-Pro-Orn-Gly-NH2(Cyclic1-6);
Molecular Formula C43H67N11O12S2;
Molar Mass 994.199 g/mol;
Purity ≥98%;
Impurity ≤0.5% ;
Storage Temperature 2-8℃;
Packing Size 1G/Bottle, 10G/Bottle,50G/Bottle or at customers reqirement.
Atosiban Acetate can postpone its imminent premature birth.
Mechanism of action: Atosiban is a nonapeptide, desamino-oxytocin analogue, and a competitive vasopressin/oxytocin receptor antagonist (VOTra). Atosiban inhibits the oxytocin-mediated release of inositol trisphosphate from the myometrial cell membrane. As a result, there is reduced release of intracellular, stored calcium from the sarcoplasmic reticulum of myometrial cells, and reduced influx of Ca2+ from the extracellular space through voltage gated channels. In addition, atosiban suppresses oxytocin-mediated release of PGE and PGF from the decidua.
Originator Company: Ferring Pharmaceuticals
Dosage for formulation: 7.5mg/ml
Generic API process in our company: Atosiban Acetate is one of our main peptide projects, related documents will be submitted to the international FDA.
Details
Atosiban Acetate
IN STOCK
QUICK OVERVIEW
Product Name Atosiban Acetate;
Cas No. 90779-69-4;
Sequence Mpa-D-Tyr(ET)-Ile-Thr-Asn-Cys-Pro-Orn-Gly-NH2(Cyclic1-6);
Molecular Formula C43H67N11O12S2;
Molar Mass 994.199 g/mol;
Purity ≥98%;
Impurity ≤0.5% ;
Storage Temperature 2-8℃;
Packing Size 1G/Bottle, 10G/Bottle,50G/Bottle or at customers reqirement.
Atosiban Acetate can postpone its imminent premature birth.
Mechanism of action: Atosiban is a nonapeptide, desamino-oxytocin analogue, and a competitive vasopressin/oxytocin receptor antagonist (VOTra). Atosiban inhibits the oxytocin-mediated release of inositol trisphosphate from the myometrial cell membrane. As a result, there is reduced release of intracellular, stored calcium from the sarcoplasmic reticulum of myometrial cells, and reduced influx of Ca2+ from the extracellular space through voltage gated channels. In addition, atosiban suppresses oxytocin-mediated release of PGE and PGF from the decidua.
Originator Company: Ferring Pharmaceuticals
Dosage for formulation: 7.5mg/ml
Generic API process in our company: Atosiban Acetate is one of our main peptide projects, related documents will be submitted to the international FDA.